跳至主要内容
临床试验/NCT00002331
NCT00002331已完成不适用

A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS

Abbott33 个研究点 分布在 2 个国家开始时间: 1994年1月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Abbott
试验地点
33

研究概览

简要总结

PRIMARY: To assess the tolerability of the combination regimen of clarithromycin plus ethambutol with or without clofazimine in patients with disseminated Mycobacterium avium Complex (dMAC).

SECONDARY: To determine the proportion of patients achieving a sterile blood culture along with the time required to achieve it. To determine the duration of bacteriological response, defined as length of time that blood cultures remain sterile.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Abbott
申办方类型
Industry

研究点 (33)

Loading locations...

相似试验

The Safety and Effectiveness of Clarithromycin Plus... | 临床试验